Previous Close | 27.72 |
Open | 27.64 |
Bid | 0.00 x 800 |
Ask | 0.00 x 800 |
Day's Range | 27.22 - 27.77 |
52 Week Range | 21.28 - 33.51 |
Volume | |
Avg. Volume | 501,727 |
Market Cap | 3.516B |
Beta (5Y Monthly) | 1.38 |
PE Ratio (TTM) | 14.34 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 0.50 (1.83%) |
Ex-Dividend Date | Feb 29, 2024 |
1y Target Est | N/A |
Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its first quarter ended March 31, 2024 on Thursday, May 2, 2024 after the market closes.
Concentra Group Holdings Parent, Inc. ("Concentra") today announced that it has confidentially submitted a draft registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the "SEC") relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The initial public offering is expected to occur after the SEC completes its review process, subject to market
Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) announced today that it has received a favorable private letter ruling from the Internal Revenue Service (the "IRS") with respect to the tax-free status of its previously announced plan to pursue a separation of its wholly-owned occupational health services business, Concentra Group Holdings Parent, LLC ("Concentra" and such business, the "Concentra business"). Details regarding the potential separation were